Open AccessZonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
Author(s) -
Lael M. Yonker,
Zoe Swank,
Tal Gilboa,
Yasmeen Senussi,
Victoria Kenyon,
Lena Papadakis,
Brittany P. Boribong,
Ryan W. Carroll,
David R. Walt,
Alessio Fasano
Publication year - 2022
Publication title -
critical care explorations
Language(s) - English
Resource type - Journals
ISSN - 2639-8028
DOI - 10.1097/cce.0000000000000641
Subject(s) - medicine , adjuvant , adverse effect , immune system , cytokine release syndrome , antibody , immunology , tight junction , respiratory system , gastroenterology , immunotherapy , chimeric antigen receptor , biology , microbiology and biotechnology